id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0021-0007,FDA,FDA-2005-N-0021,Letter from FDA CDER to  Representatives of Symrise Inc. re:  Climbazole TEA and Proctor & Gamble,Other,Letter(s),2019-08-29T04:00:00Z,2019,8,2019-08-29T04:00:00Z,,2020-10-29T12:59:54Z,,0,0,0900006483ed9393